Would a functional cure for T1D affect RVX and T2D?

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

barsax

Rank: Vice President [?]

Points: 848 [?]

Votes: 11 Score: 3.9 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Would a functional cure for T1D affect RVX and T2D?

posted on Jan 15, 2021 03:29PM

quote from the news release: "I am excited to be part of this evolution in patient treatment as we advance the Cell Pouch cell therapy approach towards a functional cure for diabetes.”

This comes from today's press release put out by Sernova (SVA:TSXV)

Its very early. Too early to claim a functional cure. 5 out of 7patients treated

https://www.thenewswire.com/press-releases/1LpMFDOv9-sernova-principal-investigator-presents-additional-positive-preliminary-safety-and-efficacy-data-from-ongoing-us-phase-i-ii-cell-pouch-clinical-trial-for-type-1-diabetes.html

So, how would this translate to our target market: patients with ACS and T2D? Any thoughts?